[
    [
        {
            "time": "2023-10-16",
            "original_text": "资金抢筹！医药监管迎风口，这些要点必看",
            "features": {
                "keywords": [
                    "资金",
                    "医药",
                    "监管",
                    "风口"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "资金抢筹！医药监管迎风口，这些要点必看",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "汪建带头增持1.5亿元 华大基因股价上午上涨6%",
            "features": {
                "keywords": [
                    "汪建",
                    "增持",
                    "华大基因",
                    "股价",
                    "上涨"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "汪建带头增持1.5亿元 华大基因股价上午上涨6%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "生物疫苗板块探底反击，千山药机、银河生物相继涨停",
            "features": {
                "keywords": [
                    "生物疫苗",
                    "板块",
                    "探底",
                    "反击",
                    "涨停"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "生物疫苗板块探底反击，千山药机、银河生物相继涨停",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "[增持评级] 生物技术行业研究：首个肿瘤二代测序伴随诊断获批 开启肿瘤精准诊治新纪元",
            "features": {
                "keywords": [
                    "生物技术",
                    "肿瘤",
                    "二代测序",
                    "伴随诊断",
                    "精准诊治"
                ],
                "sentiment_score": 0.95,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[增持评级] 生物技术行业研究：首个肿瘤二代测序伴随诊断获批 开启肿瘤精准诊治新纪元",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "华大基因一周三度宣布增持 两名高管已出手",
            "features": {
                "keywords": [
                    "华大基因",
                    "增持",
                    "高管"
                ],
                "sentiment_score": 0.88,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因一周三度宣布增持 两名高管已出手",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "华大基因实际控制人及管理层拟增持",
            "features": {
                "keywords": [
                    "华大基因",
                    "实际控制人",
                    "管理层",
                    "拟增持"
                ],
                "sentiment_score": 0.82,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因实际控制人及管理层拟增持",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]